Lotte E. Pont-Berghauser

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of COVID-19 on pharmaceutical external innovation sourcing.

Impact of COVID-19 on pharmaceutical external innovation sourcing.

Journal: Nature reviews. Drug discovery

Published: November 11, 2020

Developing blockbuster drugs: both nature and nurture.

Developing blockbuster drugs: both nature and nurture.

Journal: Nature reviews. Drug discovery

Published: June 10, 2020

TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2.

TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2.

Journal: Oncotarget

Published: January 11, 2016

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.

The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.

Journal: PloS one

Published: January 03, 2015

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.

Journal: Gene therapy

Published: December 11, 2014

ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.

ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.

Journal: Journal of translational medicine

Published: November 09, 2014

The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.

The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.

Journal: Genes & cancer

Published: August 14, 2014

Ambivalence among neurologists and neurosurgeons on the treatment of chronic subdural hematoma: a national survey.

Ambivalence among neurologists and neurosurgeons on the treatment of chronic subdural hematoma: a national survey.

Journal: Acta neurologica Belgica

Published: July 22, 2012

Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma.

Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma.

Journal: The journal of gene medicine

Published: May 10, 2012

The role of corticosteroids in the management of chronic subdural hematoma: a systematic review.

The role of corticosteroids in the management of chronic subdural hematoma: a systematic review.

Journal: European journal of neurology

Published: December 28, 2011

Currarino's triad diagnosed in an adult woman.

Currarino's triad diagnosed in an adult woman.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: November 16, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026